Trial · NCT03117140
Outcomes15
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Duration of Analgesia | 1-3 days post-operative | minutes | MEDIAN | |
| SECONDARY | Block Set up Time | Day one | minutes | MEDIAN | |
| SECONDARY | Sensory Duration of Block | Day 1-3 | minutes | MEDIAN | |
| SECONDARY | Patient Reporting Vomiting at Home | 1-3 days | 1 patient in the Plain Ropivacaine group and the Ropivacaine and Buprenorphine group did not complete the survey about vomiting at home and therefore was not included in the analysis | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Patients Vomiting in the PACU (Post-Anesthesia Care Unit) | Post-op Day 0 (Baseline) | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Patients Reporting Nausea at Home | 1-3 days | 1 patient in the Plain Ropivacaine group and the Ropivacaine and Buprenorphine group did not complete the survey about nausea at home and therefore was not included in the analysis | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Patients Reporting Nausea in the PACU | Post-op day 0 (Baseline) | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Motor Duration of Block | Day 1-3 | minutes | MEDIAN | |
| SECONDARY | Number of Patients With Blood Pressure (BP) Changes in the PACU | Post-op Day 0 (baseline) | 1 patient in Ropivacaine and Buprenorphine group did get data for the BP changes in the PACU for the study so therefore was not included in the analysis | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Patient With Blood Pressure Changes in the Second Stage Recovery Area | Post-op Day 0 (baseline) | 1 patient in Ropivacaine and Buprenorphine group did not have blood pressure data obtained in the second stage area so therefore was not included in the analysis | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Pain Score Reported by Patients at First Phone Call | Day 1-3 | units on a scale | MEDIAN | |
| SECONDARY | Number of Patients Reporting Itching in the PACU | Post-op day 0 (baseline) | 1 patient in the Ropivacaine and Buprenorphine group did not obtain data on the itching in the PACU therefore was not included in the analysis | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Patients Reporting Itching at Home | 1-3 days | Participants | COUNT_OF_PARTICIPANTS | |
| OTHER_PRE_SPECIFIED | Surgical Position | Post-op Day 0 (Baseline) | Participants | COUNT_OF_PARTICIPANTS | |
| OTHER_PRE_SPECIFIED | Surgical Length | Post op Day 0 (Baseline) | minutes | MEDIAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03117140/outcomes